Momenta taps BioFactura’s NS0 cell line tech for biosimilar candidate
By Dan Stanton 21SEP2016
Momenta Pharmaceuticals has partnered on the development of an undisclosed biosimilar using BioFactura’s StableFast biomanufacturing platform…
Momenta Pharmaceuticals has partnered on the development of an undisclosed biosimilar using BioFactura’s StableFast biomanufacturing platform…